Changes in fears and worries related to COVID-19 during the pandemic among current employees in Japan: a 5-month longitudinal study
Sign Up to like & getrecommendations! Published in 2021 at "Public Health"
DOI: 10.1016/j.puhe.2021.06.017
Abstract: Objectives This study investigates and describes the time course of fears and worries about COVID-19 among current employees during this outbreak. Study design This was a longitudinal study. Methods This study was a part of… read more here.
Keywords: fears worries; among current; current employees; study ... See more keywords
FRI0208 IDENTIFYING LUPUS PATIENT SUBSETS AND SPECIFIC PHARMACODYNAMIC CHANGES THROUGH IMMUNE CELL DECONVOLUTION OF GENE EXPRESSION DATA IN ATACICEPT-TREATED PATIENTS IN THE APRIL-SLE STUDY
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.702
Abstract: Background: The Phase 2/3 APRIL-SLE study evaluated the safety and efficacy of atacicept, a dual inhibitor of the B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), in systemic lupus erythematosus (SLE). Objectives: The goal… read more here.
Keywords: employee; current employees; expression; gene ... See more keywords
FRI0194 INTEGRATED SAFETY PROFILE OF ATACICEPT FROM ALL CLINICAL STUDIES TO DATE
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.703
Abstract: Background: We conducted an integrated analysis of pooled safety data from all 17 atacicept clinical studies across multiple indications to date. Objectives: To characterize the overall safety profile of atacicept. Methods: Analyses were based on… read more here.
Keywords: exposure adjusted; infection; emd serono; current employees ... See more keywords